These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease. Teunissen CE; van der Flier WM; Scheltens P; Duits A; Wijnstok N; Nijpels G; Dekker JM; Blankenstein RM; Heijboer AC J Alzheimers Dis; 2015; 44(3):809-13. PubMed ID: 25352450 [TBL] [Abstract][Full Text] [Related]
6. Altered serum levels of adipokines and insulin in probable Alzheimer's disease. Khemka VK; Bagchi D; Bandyopadhyay K; Bir A; Chattopadhyay M; Biswas A; Basu D; Chakrabarti S J Alzheimers Dis; 2014; 41(2):525-33. PubMed ID: 24625795 [TBL] [Abstract][Full Text] [Related]
7. Serum adipokine levels modified by donepezil treatment in Alzheimer's disease. Pákáski M; Fehér A; Juhász A; Drótos G; Fazekas OC; Kovács J; Janka Z; Kálmán J J Alzheimers Dis; 2014; 38(2):371-7. PubMed ID: 23979024 [TBL] [Abstract][Full Text] [Related]
8. Plasma leptin levels and free leptin index in women with Alzheimer's disease. Baranowska-Bik A; Bik W; Styczynska M; Chodakowska-Zebrowska M; Barcikowska M; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B Neuropeptides; 2015 Aug; 52():73-8. PubMed ID: 26070219 [TBL] [Abstract][Full Text] [Related]
9. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U Respiration; 2004; 71(1):45-50. PubMed ID: 14872110 [TBL] [Abstract][Full Text] [Related]
10. Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years. Gilbert T; Roche S; Blond E; Bar JY; Drai J; Cuerq C; Haution-Bitker M; Ecochard R; Bonnefoy M J Alzheimers Dis; 2018; 66(3):1255-1264. PubMed ID: 30400097 [TBL] [Abstract][Full Text] [Related]
11. Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer. Brown DR; Berkowitz DE; Breslow MJ J Clin Endocrinol Metab; 2001 Jan; 86(1):162-6. PubMed ID: 11231995 [TBL] [Abstract][Full Text] [Related]
12. The cause-effect relationship between bone loss and Alzheimer's disease using statistical modeling. Loskutova N; Watts AS; Burns JM Med Hypotheses; 2019 Jan; 122():92-97. PubMed ID: 30593432 [TBL] [Abstract][Full Text] [Related]
13. Effects of Gender and Other Confounding Factors on Leptin Concentrations in Alzheimer's Disease: Evidence from the Combined Analysis of 27 Case-Control Studies. Zhou F; Chen S J Alzheimers Dis; 2018; 62(1):477-486. PubMed ID: 29439354 [TBL] [Abstract][Full Text] [Related]
14. Circulating leptin and body composition in chronic obstructive pulmonary disease. Karakas S; Karadag F; Karul AB; Gurgey O; Gurel S; Guney E; Cildag O Int J Clin Pract; 2005 Oct; 59(10):1167-70. PubMed ID: 16178984 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484 [TBL] [Abstract][Full Text] [Related]
16. Effects of weight change on plasma leptin concentrations and energy expenditure. Rosenbaum M; Nicolson M; Hirsch J; Murphy E; Chu F; Leibel RL J Clin Endocrinol Metab; 1997 Nov; 82(11):3647-54. PubMed ID: 9360521 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychological syndromes associated with Alzheimer's/vascular dementia: a latent class analysis. Libon DJ; Drabick DA; Giovannetti T; Price CC; Bondi MW; Eppig J; Devlin K; Nieves C; Lamar M; Delano-Wood L; Nation DA; Brennan L; Au R; Swenson R J Alzheimers Dis; 2014; 42(3):999-1014. PubMed ID: 25024329 [TBL] [Abstract][Full Text] [Related]
18. Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. McGuire MJ; Ishii M Cell Mol Neurobiol; 2016 Mar; 36(2):203-17. PubMed ID: 26993509 [TBL] [Abstract][Full Text] [Related]
19. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia. Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460 [TBL] [Abstract][Full Text] [Related]
20. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Lorenzl S; Buerger K; Hampel H; Beal MF Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]